# Galectin-3 for Thromboembolic Formation in Patients With Atrial Fibrillation CHA₂DS₂-VASc Scoring

> **NCT03413072** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 140 (estimated)

## Conditions studied

- Atrial Fibrillation
- Stroke

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03413072
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06
- **Primary completion:** 2019-06
- **Final completion:** 2020-06
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2018-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03413072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03413072, "Galectin-3 for Thromboembolic Formation in Patients With Atrial Fibrillation CHA₂DS₂-VASc Scoring". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03413072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*